8. Полное описание см. в: http://omim.org/entry/309550
.9. Ashley CT Jr, Wilkinson KD, Reines D, Warren ST. FMR1 protein: conserved RNP family domains and selective RNA binding.
10. Qin M, Kang J, Burlin TV, Jiang C, Smith CB. Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse.
11. Azevedo FA, Carvalho LR, Grinberg LT, Farfel JM, Ferretti RE, Leite RE, Jacob Filho W, Lent R, Herculano-Houzel S. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain.
12. Drachman DA. Do we have brain to spare?
13. Darnell JC, Van DriescheSJ, ZhangC, Hung KY, Mele A, FraserCE, Stone EF, Chen C, Fak JJ, Chi SW, Licatalosi DD, Richter JD, Darnell RB. FMRP stalls ribosomal translocation on messenger RNAs linked to synaptic function and autism.
14. Udagawa T, Farny NG, Jakovcevski M, Kaphzan H, Alarcon JM, Anilkumar S, Ivshina M, Hurt JA, Nagaoka K, Nalavadi VC, Lorenz LJ, Bassell GJ, Akbarian S, Chattarji S, Klann E, Richter JD. Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology.
15. Кратко изложено в: http://www.ncbi.nlm.nih.gov/books/NBK1165
.16. Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons.
17. Savkur RS, Philips AV, Cooper ТА. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
18. HoTH, Charlet-BN, Poulos MG, Singh G, Swanson MS, Cooper ТА. Muscleblind proteins regulate alternative splicing.
19. Kino Y, Washizu C, Oma Y, Onishi H, Nezu Y, Sasagawa N, Nukina N, Ishiura S. MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1.
20. Hanson EL, Jakobs PM, Keegan H,Coates K, BousmanS, Dienel NH, Litt M, Hershberger RE. Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy.
21. Цит. no: Michalova E, Vojtesek B, Hrstka R. Impaired pre-messenger RNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders.
22. Полное описание синдрома см. в: http://ghr.nlm.nih.gov/
condition / immune-dysregulation-polyendocrinopathy-enteropa-thy-x-linked-syndrome.23. Bennett CL, Brunkow ME, Ramsdell F, O’Briant КС, Zhu Q, Fuleihan RL, Shigeoka AO, Ochs HD, Chance PF. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-»AAUGAA) leads to the IPEX syndrome.
24. Подробнее см. в: http://www.alsa.org
.25. Базу данных генов, которые, как полагают, играют какую-то роль в развитии БАС, можно найти здесь: http://alsod.iop.kcl.ac.uk
.26. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosier BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH Jr. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophie lateral sclerosis.
27. Vance C, Rogelj B, Hortobâgyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, Tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE. Mutations in FUS, an RNA processing protein, cause familial amyotrophie lateral sclerosis type 6.
28. Lai SL, Abramzon Y, Schymick JC, Stephan DA, Dunckley T, Dillman A, Cookson M, Calvo A, Battistini S, Giannini F, Caponnetto C, Mancardi GL, Spataro R, Monsurro MR, Tedeschi G, Marinou K, Sabatelli M, Conte A, Mandrioli J, Sola P, Salvi F, Bartolomei I, Lombardo F; ITALSGEN Consortium, Mora G, Restagno G, Chiô A, Traynor BJ. FUS mutations in sporadic amyotrophie lateral sclerosis.